Old Web
English
Sign In
Acemap
>
authorDetail
>
Zheng Huang Devine
Zheng Huang Devine
Janssen Pharmaceutica
Pharmacology
Thrombin time
Thrombin
Chemistry
In vivo
5
Papers
4
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Translational PK/PD and model-informed development of JNJ-67842125, a Fab reversal agent for JNJ-64179375, a long-acting thrombin inhibitor.
2021
British Journal of Pharmacology
Vivaswath S Ayyar
Pharavee Jaiprasart
Brian Geist
Zheng Huang Devine
Case Martin A
Anasuya Hazra
Chyi-Hung Hsu
Madhu Chintala
Weirong Wang
Show All
Source
Cite
Save
Citations (0)
FEIBA® and Novoseven® Neutralize the Anticoagulant Effects of a Novel Small Molecule FXIa Inhibitor BMS-986177/JNJ-70033093 in Human Plasma and Whole Blood in Vitro
2020
Blood
Matthew Bunce
Zheng Huang Devine
Madhu Chintala
Show All
Source
Cite
Save
Citations (1)
Pharmacological Profile of JNJ-64179375: A Novel, Long Acting Exosite-1 Thrombin Inhibitor
2019
Journal of Pharmacology and Experimental Therapeutics
Zheng Huang Devine
Fuyong Du
Qiu Li
Matthew Bunce
Eilyn R. Lacy
Madhu Chintala
Show All
Source
Cite
Save
Citations (2)
Preferential Inhibition of Fibrin Mediated Thrombosis in Rodent Models By JNJ-9375, a Novel exosite1 Thrombin Inhibitor
2017
Blood
Madhu Chintala
Qiu Li
Zheng Huang Devine
Matthew Bunce
Show All
Source
Cite
Save
Citations (1)
Measuring the Anticoagulation Effects of Exosite I Thrombin Inhibitors: Utility and Limitations of Clotting Assays, Thromboelastography, and Calibrated Automated Thrombography
2017
Blood
Matthew Bunce
Zheng Huang Devine
Madhu Chintala
Show All
Source
Cite
Save
Citations (0)
1